Atypical Pneumonia Panel
NY State Approved Indicates the status of NY State approval and if the test is orderable for NY State clients.
Profile Information A profile is a group of laboratory tests that are ordered and performed together under a single Mayo Test ID. Profile information lists the test performed, inclusive of the test fee, when a profile is ordered and includes reporting names and individual availability.
|Test ID||Reporting Name||Available Separately||Always Performed|
|CHPA1||Chlamydia and Chlamydophila Ab Pnl||No||Yes|
|FLEGA||Legionella Pneumophila Ab (Total)||No||Yes|
|FMPAG||M. Pneumoniae Ab IgG||No||Yes|
|FMPAM||M. Pneumoniae Ab IgM||No||Yes|
Immunofluorescence Assay (IFA)/Enzyme-Linked Immunosorbent Assay (ELISA)
Reporting Name A shorter/abbreviated version of the Published Name for a test; an abbreviated test name
Atypical Pneumonia Panel
Specimen Type Describes the specimen type needed for testing
Specimen Required Defines the optimal specimen. This field describes the type of specimen required to perform the test and the preferred volume to complete testing. The volume allows automated processing, fastest throughput and, when indicated, repeat or reflex testing.
Draw blood in a plain red-top tube(s), serum gel tube(s) is acceptable. Spin down and send 3 mL of serum refrigerated in a plastic vial.
Specimen Minimum Volume Defines the amount of specimen required to perform an assay once, including instrument and container dead space. Submitting the minimum specimen volume makes it impossible to repeat the test or perform confirmatory or perform reflex testing. In some situations, a minimum specimen volume may result in a QNS (quantity not sufficient) result, requiring a second specimen to be collected.
Warm OK; Cold OK
Specimen Stability Information Provides a description of the temperatures required to transport a specimen to the laboratory. Alternate acceptable temperature(s) are also included.
|Serum||Refrigerated (preferred)||7 days|
Reference Values Describes reference intervals and additional information for interpretation of test results. May include intervals based on age and sex when appropriate. Intervals are Mayo-derived, unless otherwise designated. If an interpretive report is provided, the reference value field will state this.
Chlamydia and Chlamydophila Antibody Panel 3 (IgG, IgA, IgM)
C.Trachomatis, C.Pneumoniae, C.Psittaci (IgG, IgA, IgM )
Reference Range: IgG < 1:64
IgA < 1:16
IgM < 1:10
The immunofluorescent detection of specific antibodies to Chlamydia trachomatis, Chlamydophila pneumoniae, and C. psittaci may be complicated by crossreactive antibodies, non-specific antibody stimulation, or past exposure to more than one of these organisms. IgM titers of 1:10 or greater are indicative of recent infection; however, IgM antibody is very crossreactive, often demonstrating titers to multiple organisms. Any IgG titer may indicate past exposure to that particular organism. Infection by a particular organism typically yields IgG titers that are higher than antibody titers to non-infecting organisms. IgA titers may help to identify the infecting organism when crossreactive IgG is present. IgA is typically present at low titers during primary infection, but may be elevated in recurrent exposures or in chronic infection.
Legionella Pneumophila Antibodies (Total)
L. pneumophila (serogroup 1) and (serogroups 2-6, 8)
Reference Ranges: <1:16
Total antibodies to Legionella pneumophila serogroup 1 and 6 additional L. pneumophila serogroups (2, 3, 4, 5, 6, 8) are measured using a polyvalent conjugate.
The antibody response to Legionella may be detected 4 days to 6 weeks after exposure and may remain elevated for months or years. Thus, a fourfold or greater rise in titer is required to confirm a diagnosis of current infection. Serologic testing does not usually allow definitive differentiation of Legionella serogroups.
Mycoplasma Pneumoniae Antibody (IgG)
Reference Range: <=0.90
A positive result indicates that the patient has antibody to Mycoplasma. It does not differentiate between an active or past infection. The clinical diagnosis must be interpreted in conjunction with the clinical signs and symptoms of the patient.
Mycoplasma Pneumoniae Antibody (IgM)
Reference Range: <770 U/mL
<770 U/mL Negative
770-950 U/mL Low positive
>950 U/mL Positive
Test Performed by: Focus Diagnostics, Inc.
785 Corporate Avenue
Cypress, CA 90630-4750
Day(s) and Time(s) Test Performed Outlines the days and times the test is performed. This field reflects the day and time the sample must be in the testing laboratory to begin the testing process and includes any specimen preparation and processing time required before the test is performed. Some tests are listed as continuously performed, which means assays are performed several times during the day.
Monday through Saturday; Varies
Analytic Time Defines the amount of time it takes the laboratory to setup and perform the test. This is defined in number of days. The shortest interval of time expressed is "same day/1 day," which means the results may be available the same day that the sample is received in the testing laboratory. One day means results are available 1 day after the sample is received in the laboratory.
1 - 4 days
Maximum Laboratory Time Defines the maximum time from specimen receipt at Mayo Medical Laboratories until the release of the test result
3 - 8 days
Performing Laboratory Location The location of the laboratory that performs the test
Focus Diagnositics, Inc.
Test Classification Provides information regarding the medical device classification for laboratory test kits and reagents. Tests may be classified as cleared or approved by the US Food and Drug Administration (FDA) and used per manufacturer's instructions, or as products that do not undergo full FDA review and approval, and are then labeled as an Analyte Specific Reagent (ASR), Investigation Use Only (IUO) product, or a Research Use Only (RUO) product.
These assays were developed and their performance characteristics have been determined by Focus Diagnostics. They have not been cleared or approved by the U.S. Food and Drug Administration. The FDA has determined that such clearance or approval is not necessary. Performance characteristics refer to the analytical performance of the test.
CPT Code Information Provides guidance in determining the appropriate Current Procedural Terminology (CPT) code(s) information for each test or profile. The listed CPT codes reflect Mayo Medical Laboratories interpretation of CPT coding requirements. It is the responsibility of each laboratory to determine correct CPT codes to use for billing.
86631 x6 Chlamydia
86632 x3 Chlamydia, IgM
86713 x2 Legionella
86738 x2 Mycoplasma
LOINC® Code Information Provides guidance in determining the Logical Observation Identifiers Names and Codes (LOINC) values for the result codes returned for this test or profile.
|Result ID||Reporting Name||LOINC Code|
|Z0314||C. Trachomatis IgG||6919-5|
|Z0595||L. Pneumophila (Serogroup 1)||7948-3|
|FMPAG||M. Pneumoniae Ab IgG||In Process|
|FMPAM||M. Pneumoniae Ab IgM||In Process|
|Z0347||L. Pneumophila (Serogroup 2-6,8)||In Process|
|Z0327||C. Trachomatis IgA||6918-7|
|Z0315||C. Trachomatis IgM||6920-3|
|Z0574||C. Pneumoniae IgG||6913-8|
|Z0326||C. Pneumoniae IgA||6912-0|
|Z0313||C. Pneumoniae IgM||6914-6|
|Z0316||C. Psittaci IgG||6916-1|
|Z0328||C. Psittaci IgA||In Process|
|Z0317||C. Psittaci IgM||6917-9|